SkinBioTherapeutics plc (LON:SBTX – Get Free Report) shot up 8.8% during trading on Thursday . The company traded as high as GBX 9.37 ($0.12) and last traded at GBX 9.25 ($0.12). 476,184 shares were traded during mid-day trading, a decline of 25% from the average session volume of 636,981 shares. The stock had previously closed at GBX 8.50 ($0.11).
SkinBioTherapeutics Price Performance
The business has a 50-day simple moving average of GBX 9.47 and a 200 day simple moving average of GBX 10.89. The stock has a market cap of £18.54 million, a P/E ratio of -425.00 and a beta of 1.67. The company has a current ratio of 6.57, a quick ratio of 10.01 and a debt-to-equity ratio of 2.66.
SkinBioTherapeutics Company Profile
SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis.
Recommended Stories
- Five stocks we like better than SkinBioTherapeutics
- There Are Different Types of Stock To Invest In
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- Ride Out The Recession With These Dividend Kings
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Conference Calls and Individual Investors
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for SkinBioTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SkinBioTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
